119 results
8-K
ONCT
Oncternal Therapeutics Inc
16 Sep 05
GTx Announces Public Offering of Common Stock
12:00am
supplier to do so. The term of the amended and restated agreement lasts, on a country-by-country basis, until the later of expiration of our own … in transferring such know-how to us or another supplier chosen by us.
The term of the amended and restated agreement lasts, on a country-by-country basis
10-K
2003 FY
EX-14.1
ONCT
Oncternal Therapeutics Inc
26 Mar 04
Annual report
12:00am
business not on behalf of GTx with any
consultant, contractor, supplier, scientific collaborator or
any … , contractor, supplier or scientific
collaborator may not be released to third parties or government or other
organizations, without the written consent
CORRESP
ONCT
Oncternal Therapeutics Inc
19 Jan 11
Correspondence with SEC
12:00am
supplier for toremifene-based products. However, any arrangements we make for an alternative supply would have to be made with a qualified alternative … supplier with appropriate FDA approval in order for us to obtain our supply requirements for toremifene. The term of the amended and restated license
8-K
ONCT
Oncternal Therapeutics Inc
13 Dec 06
GTx Announces Registered Direct Common Stock Offering of $60.8 Million
12:00am
an amended supply agreement with Orion. As such, both we and Ipsen rely on Orion as the single source supplier of ACAPODENE®.
In the event that Orion … to manufacture ACAPODENE®, but any arrangements we make for an alternative supply would still have to be made with a qualified alternative supplier
CORRESP
sggvwaz7
21 Dec 10
Correspondence with SEC
12:00am
424B5
g5ea33hy1s9xrtc0tm6r
12 Oct 05
Prospectus supplement for primary offering
12:00am
424B5
pbbn36fyx9sm qurhm
11 Oct 05
Prospectus supplement for primary offering
12:00am
424B5
7qu4r6b6m
16 Sep 05
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
znpjwy3pq3 4cp
26 Oct 10
GTx Announces Proposed Public Offering of Common Stock
12:00am
424B5
x65 vlvrgjt66fc
14 Dec 06
Prospectus supplement for primary offering
12:00am
424B5
ca6myaqnj196d7gl d9
14 Dec 06
Prospectus supplement for primary offering
12:00am
S-1
t61pmh
15 Oct 03
IPO registration
12:00am
S-4
EX-10.65
qpxwawkz6io
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm